Zobrazeno 1 - 10
of 63
pro vyhledávání: '"EGFR Protein Overexpression"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplification
Autor:
Marie Colombe Agahozo, Lindy L. Visser, Winand N.M. Dinjens, Jelle Wesseling, Ronald van Marion, Esther H. Lips, Carolien H.M. van Deurzen, Peggy N. Atmodimedjo, Hein F.B.M. Sleddens, Mieke Van Bockstal
Publikováno v:
Molecular Oncology
Molecular Oncology, 14(4), 671-685. John Wiley & Sons Ltd.
Molecular oncology, Vol. 14, no.4, p. 671-685 (2020)
Molecular Oncology, Vol 14, Iss 4, Pp 671-685 (2020)
Molecular Oncology, 14(4), 671-685. John Wiley & Sons Ltd.
Molecular oncology, Vol. 14, no.4, p. 671-685 (2020)
Molecular Oncology, Vol 14, Iss 4, Pp 671-685 (2020)
Intratumour heterogeneity fuels carcinogenesis and allows circumventing specific targeted therapies. HER2 gene amplification is associated with poor outcome in invasive breast cancer. Heterogeneous HER2 amplification has been described in 5–41% of
Autor:
Rina Jiromaru, Takahiro Hongo, Takashi Nakagawa, Yui Nozaki, Kazuki Hashimoto, Muneyuki Masuda, Yoshinao Oda, Kenichi Taguchi, Hidetaka Yamamoto, Ryuji Yasumatsu
Publikováno v:
American Journal of Surgical Pathology. 44:305-315
The prevalence and prognostic value of human papillomavirus (HPV) infection and epidermal growth factor receptor (EGFR) alteration in sinonasal squamous cell carcinoma (SNSCC) are not known. The reliability of p16 overexpression as a surrogate for HP
Autor:
Yuxiang He, Zhaoyang Zeng, Shengnan Chen, Wei Xiong, Bo Xiang, Wei Liu, Yixin Tan, Guiyuan Li, Tang Youhong, Jing Cai, Xiaoling Li, Mei Yi, Yuanyuan Ban
Publikováno v:
Carcinogenesis
Nasopharyngeal carcinoma (NPC) is notorious for its aggressiveness and high metastatic potential. NPC patients with distant metastasis have a particularly poor prognosis; however, evaluating metastatic potential by expression profiles of primary tumo
Autor:
Wan Atiqah Najiah Wan Hasan, Sharifah Noor Akmal Syed Husain, Sayyidi Hamzi Abdul Raub, Azlah Kamilah Azhari, Muhamad Farid Zulkifle, Jeyanthy Eswaran, Meera Soundararajan, Zubaidah Zakaria
Publikováno v:
OncoTargets and Therapy. 12:7749-7756
Background Epidermal growth factor receptor (EGFR) is a member of the ErbB family of tyrosine kinase receptor proteins that plays important roles in tumour cell survival and proliferation. EGFR has been reported to be overexpressed in up to 78% of tr
Autor:
Chun-Ta Liao, Wen-Yu Chuang, Chih-Hsiung Lai, Hung-Ming Wang, Shiang-Fu Huang, Sou-De Cheng, Huei-Tzu Chien
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Scientific Reports
Scientific Reports
This study was designed to explore the relationship between epidermal growth factor receptor (EGFR) CA repeats polymorphism and protein expression in oral cavity squamous cell carcinoma (OSCC). A total of 194 OSCCs were examined for EGFR protein over
Autor:
Joanne Xiu, Idris Tolgay Ocal, E Discianno, J. McGill, Semir Vranic, Sandeep K. Reddy, Barbara A. Pockaj, Souzan Sanati, Anatole Ghazalpour, Ryan Bender, Zoran Gatalica
Publikováno v:
Cancer Research. 76:P4-09
Introduction: Malignant phyllodes tumors are rare breast malignancies (0.1% of all breast tumors) with limited effective treatment options for recurrent and metastatic disease. Recent trials indicated a potential for anti-angiogenic therapy in soft t
Autor:
Santhoshi Bandla, Yali Zhai, Andrew S. McDaniel, Paul D. Williams, Jeffrey S. Montgomery, Chia Jen Liu, Andi K. Cani, Seth Sadis, Todd M. Morgan, Alon Z. Weizer, Javed Siddiqui, Scott A. Tomlins, Kathleen R. Cho, Ajjai Alva, Felix Y. Feng, Yajia Zhang, Rohit Mehra, Daniel R. Rhodes, Daniel H. Hovelson
Publikováno v:
Cancer Research. 75:5219-5227
Penile squamous cell carcinoma (PeSCCA) is a rare malignancy for which there are limited treatment options due to a poor understanding of the molecular alterations underlying disease development and progression. Therefore, we performed comprehensive,
Autor:
Barbara A. Pockaj, Zoran Gatalica, Joanne Xiu, John McGill, Idris Tolgay Ocal, Sandeep K. Reddy, Ryan Bender, Juan P. Palazzo, Souzan Sanati, Aaron Schlum, Semir Vranic, Erin Discianno, Anatole Ghazalpour
Publikováno v:
Oncotarget
Malignant phyllodes tumor is a rare breast malignancy with sarcomatous overgrowth and with limited effective treatment options for recurrent and metastatic cases. Recent clinical trials indicated a potential for anti-angiogenic, anti-EGFR and immunot
Publikováno v:
Applied Immunohistochemistry & Molecular Morphology. 23:653-660
AIM This study evaluated wild-type EGFR, E746-A750 frame deletion in exon 19, and L858R point mutation in exon 21 by immunohistochemistry in patients with triple-negative breast cancer (TNBC). METHODS A retrospective study included 99 untreated early